The document discusses reasons for withdrawing drugs from the market and provides some examples. It notes that the most common reasons for withdrawal are hepatotoxicity and immune-mediated reactions. A review found that 462 drugs were withdrawn between 1953 and 2013, with 72% being withdrawn due to anecdotal reports and 30-25% due to death. Some drugs are withdrawn in only one country. The document then provides three examples of drugs that were withdrawn, including the drug Adderall XR which was initially withdrawn in Canada due to risk of stroke but then reintroduced.